IP Library Patent Application 12827731
Patent Application
App. No. 12/827,731

OPHTHALMIC COMPOSITIONS CONTAINING POLYSACCHARIDE-BORATE GELLING SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/827,731
Abstract

Topical ophthalmic compositions that form a gel or partial gel upon application to the eye are described. The compositions are particularly useful as artificial tears and ocular lubricants, but may also be utilized for the topical delivery of pharmaceutically active compounds to the eye. The compositions contain a polysaccharide/borate gelling system. The polysaccharides that may be utilized contain cis-diol groups and have a structure that is predominately linear, with a slight degree of branching.

Claims (15)

1 . An ophthalmic composition that forms a gel or partial gel upon topical application of the composition to the eye of a human or other mammal, said composition containing an amount of polysaccharide/borate gelling system sufficient to facilitate the formation of said gel or partial gel, wherein the polysaccharide is not galactomannan and:

(i) has a structure that is predominately linear with less than one branched group per five sugar moieties;

(ii) contains cis-diol groups;

(iii) has α or β linkages at the 1,4-position within the sugar moieties; and

(iv) has a molecular weight of greater than 10,000 Daltons.

2 . A composition according to claim 1 , wherein said polysaccharide is glucomannan.

3 . A composition according to claim 1 , wherein said polysaccharide does not comprise galactan or mannan.

4 . A composition according to claim 1 , further comprising a therapeutically effective amount of a pharmaceutically active compound.

5 . A method of delivering a pharmaceutically active compound to the eye, which comprises topically applying the composition of claim 4 to the affected eye.

6 . A method of treating dry eye conditions, which comprises applying the composition of claim 1 to the eye.

7 . An ophthalmic composition that forms a gel or partial gel upon topical application of the composition to the eye of a human or other mammal, said composition containing an amount of polysaccharide/borate gelling system sufficient to facilitate the formation of said gel or partial gel, wherein the polysaccharide is selected from the group consisting of:

galactans, xylans, arabinans, rhamanans, and combinations thereof

8 . A composition according to claim 7 wherein the polysaccharide is an arabinan.

9 . A composition according to claim 8 wherein the arabinan is arabinogalactan.

10 . A composition according to claim 8 wherein said arabinan does not comprise galactose or mannose.

Assignments (1)
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →